SAFETY OF UVARIA CHAMAE P. BEAUV ROOTS AQUEOUS EXTRACTS IN WISTAR RATS
Journal: International Journal of Advanced Research (Vol.10, No. 05)Publication Date: 2022-05-17
Authors : Lokonon Jacques Ezechiel Agbogba Felicienne Medoatinsa Esperance Abissi Gloria Tchogou Pascal Koudoro Yaya Agbangnan Pascal Anago Eugenie Akpovi D. Casimir; Senou Maximin;
Page : 782-787
Keywords : Sickle Cell Disease Uvaria Chamae Acute Toxicity Sub-Chronic Toxicity Benin;
Abstract
Uvaria chamae is used in the treatment of sickle cell crisis in Benin. The aim of this work is to determine the safety of Uvaria chamae roots aqueous extract in wistar rats. The aqueous extract was obtained by maceration. The tests for Acute Oral Toxicity (AOT) and of Sub-Chronic Oral Toxicity (SCT) respectively by forced gavage in a single dose of 2000 mg / Kg and 200 mg / Kg of body weight for 28 days were performed on female Wistar rats. The weight of the animals, serum creatinine, transaminases and the number of white blood cells were determined on day 0 and then on day 14 and day 28 respectively for AOT and SCT. Histologic analysis of the liver, kidneys and spleen was performed for both tests. There were no deaths in toxicity testing and organ histology did not show atypia. Weight, serum AST and ALT transaminases, and mean white blood cell count did not change significantly between the start and end of the experiment for both AOT and SCT. Only creatinine decreased significantly for SCT, indicating more protection of kidney function. Uvaria chamae roots did not show hepatic, renal and immune toxicity in the acute or sub-chronic state.
Other Latest Articles
- ARTERIAL BLOOD GAS ANALYSIS PROFILE IN EXTREMELY PREMATURE NEONATES ADMITTED IN A TERTIARY CARE NEONATAL INTENSIVE CARE UNIT
- Application of Medicinal Plants on Menopause Symptoms
- Principles of Diagnosis and Treatment of Patients with Diagnosis of Covid-19 and Developing Viral Pneumonia
- Comparative Study of Solubility of Tranquilizers (Alternative Date Rape Drugs) in Stomach Acid
- New Treatment Options in Rare Diseases
Last modified: 2022-06-21 16:53:51